Retroperitoneal hematoma

Retroperitoneal hematoma
Retroperitoneal hematoma. (Image courtesy of RadsWiki)

WikiDoc Resources for Retroperitoneal hematoma
Articles
Most recent articles on Retroperitoneal hematoma Most cited articles on Retroperitoneal hematoma Review articles on Retroperitoneal hematoma Articles on Retroperitoneal hematoma in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Retroperitoneal hematoma Images of Retroperitoneal hematoma Photos of Retroperitoneal hematoma Podcasts & MP3s on Retroperitoneal hematoma Videos on Retroperitoneal hematoma
Evidence Based Medicine
Cochrane Collaboration on Retroperitoneal hematoma Bandolier on Retroperitoneal hematoma TRIP on Retroperitoneal hematoma
Clinical Trials
Ongoing Trials on Retroperitoneal hematoma at Clinical Trials.gov Trial results on Retroperitoneal hematoma Clinical Trials on Retroperitoneal hematoma at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Retroperitoneal hematoma NICE Guidance on Retroperitoneal hematoma NHS PRODIGY Guidance FDA on Retroperitoneal hematoma CDC on Retroperitoneal hematoma
Books
Books on Retroperitoneal hematoma
News
Retroperitoneal hematoma in the news Be alerted to news on Retroperitoneal hematoma News trends on Retroperitoneal hematoma
Commentary
Blogs on Retroperitoneal hematoma
Definitions
Definitions of Retroperitoneal hematoma
Patient Resources / Community
Patient resources on Retroperitoneal hematoma Discussion groups on Retroperitoneal hematoma Patient Handouts on Retroperitoneal hematoma Directions to Hospitals Treating Retroperitoneal hematoma Risk calculators and risk factors for Retroperitoneal hematoma
Healthcare Provider Resources
Symptoms of Retroperitoneal hematoma Causes & Risk Factors for Retroperitoneal hematoma Diagnostic studies for Retroperitoneal hematoma Treatment of Retroperitoneal hematoma
Continuing Medical Education (CME)
CME Programs on Retroperitoneal hematoma
International
Retroperitoneal hematoma en Espanol Retroperitoneal hematoma en Francais
Business
Retroperitoneal hematoma in the Marketplace Patents on Retroperitoneal hematoma
Experimental / Informatics
List of terms related to Retroperitoneal hematoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Retroperitoneal hemorrhage and retroperitoneal hematoma are potentially life-threatening conditions. Common causes of retroperitoneal hemorrhage are cardiac catheterization and trauma.

Symptoms

The patient may complain of intense flank pain or back pain.

Signs

The patient may develop tachycardia and hypotension if the rate of hemorrhage is rapid.

Rarely, later in the course, the patient may develop a Grey-Turner's sign with bulging flanks, and a bluish discoloration in the region of the flank. Again, it should be emphasized that this sign appears 24 to 48 hours after a severe retroperitoneal bleed and should not be used to gauge whether a retroperitoneal bleed is present acutely.

Diagnostic Findings

MRI

(Images courtesy of RadsWiki)

• 

  MRI demonstrates a right sided retroperitoneal hematoma

• 

  MRI demonstrates a right sided retroperitoneal hematoma

• 

  MRI demonstrates a right sided retroperitoneal hematoma

Treatment

Pharmacologic

Discontinuation of anti-coagulation

If possible anticoagulation therapy including both antithrombins and antiplatelet agents should be discontinued. One exception is if the patient has had a coronary stent placed, in which case dual antiplatelet therapy should be continued if at all possible. If Clopidogrel must be discontinued, then low dose aspirin should be continued in a patient with a fresh stent.

Reversal of anti-coagulation

Antithrombins

If the patient has received unfractionated heparin, protamine can be used to reverse the heparin. Protamine does partially reverse enoxaparin as well. Bivalirudin has a fairly short half-life, and does not require reversal.

Antiplatelets

If the antiplatelet effects must be overcome acutely, then a platelet transfusion can be administered. However, if the antiplatelet agents on board do not bind avidly to the platelets, then these agents can then bind to the new platelets that have just been transfused. Small molecule 2b3a inhibitors such as eptifibatide and Aggrastat are examples of these types of agents. Agents that permanently inhibit the platelet such as aspirin and Clopidogrel can take up to five days to reverse (the time that it takes for new platelets to form).

Surgery

After blunt trauma, selected retroperitoneal hematomas in the lateral perirenal and pelvic areas do not require operation and should not be opened if discovered at operation. Midline, lateral paraduodenal, lateral pericolonic not associated with pelvic, and portal hematomas are opened after proximal vascular control has been obtained, if appropriate.

Retrohepatic hematomas without obvious active hemorrhage are not opened. After penetrating trauma, most retroperitoneal hematomas are still opened. Exceptions include isolated lateral perirenal hematomas that have been carefully staged by CT and some lateral pericolonic hematomas. As with blunt trauma, retrohepatic hematomas without obvious active hemorrhage are not opened.